Genetic study of hereditary thrombophilia aimed at the identification of patients with an increased risk of developing thromboembolic disease. To do this, NIMGenetics offers a comprehensive and updated test whose estimation of risk is based on quantitative and specific criteria of each of the genomic positions analyzed.
The test analyzes 24 variants in 18 genes associated with an increase in thrombotic risk. It includes genes involved in multiple molecular pathways involved in hereditary thrombophilia.
When is it indicated?
Genetic studies of thrombophilia are indicated in the following situations:
- Personal history of thromboembolic disease:
- Deep vein thrombosis or recurrent thrombophlebitis
- Pulmonary embolism
- Recurrent miscarriage
- Treatments with oral contraceptives, hormone replacement therapy and fertilization cycles.
- Family history of venous thrombosis.
- Other risk factors: pregnancy, obesity, smoking, advanced age, pathologies associated with thrombophilia and prolonged immobilization.